Newly Approved Treatment for Genotypes 1-6 Chronic HCV


Science & Innovation Theater Webinar 


Newly Approved Treatment for Genotypes 1-6 Chronic HCV
Sponsored by Abbvie

Wednesday, September 27, 2017, 2-3pm, EDT

Approximately 3.4 million people in the US are infected with chronic HCV. Please join us to learn about the newest innovation in the treatment of HCV.


Robert S. Brown, Jr., M.D., M.P.H.
Gladys and Roland Harriman Professor of Medicine
Vice Chair, Transitions of Care
Clinical Chief, Division of Gastroenterology & Hepatology
Weill Cornell Medicine
Center for Liver Disease

This webinar is sponsored, developed and presented by the sponsor.  The content of the Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy. 

Sponsored by:  

  Abbvie Logo 

** IMPORTANT: AMCP webinars are limited to the first 500 that join the webinar. However, AMCP will provide a link to the recording and slides to all registrants within a week from the webinar date. The recording and slides of sponsored webinars will be provided if permitted by the sponsor.